Serotonin Flashcards
1
Q
Describe where serotonin is mostly found
A
- 90% of the 5-HT in your body is found in the gut
- 5-HT is a major neurotransmitter in the enteric nervous system and is released by enterochromaffin cells
- 5-HT stimulates peristalsis and
secretion into the intestines - 5-HT is massively released in response to chemical, physical, or pathological stimuli and can activate vagal afferents to signal the brain in generation of nausea & act at the area postrema (chemoreceptor trigger zone)
2
Q
Describe serotonin synthesis and catabolism
A
Dietary L-tryptophan is transported into the brain where it is converted to 5-HT by tryptophan hydroxylase (the rate limiting enzyme).
5-HT is deaminated by monoamine oxidase to 5-hydroxyindoleacetic acid in the cytoplasm of seratonergic neurons
In contrast to the catecholamines, 5-HT breakdown occurs only through MAO.
3
Q
Describe tryptophan depletion
A
- Para-chlorophenylalanine (PCPA) is used in animals to rapidly deplete 5-HT
- PCPA is an irreversible inhibitor of tryptophan hydroxylase
- 1-2 doses depletes 5-HT by up to 90% for up to 2 weeks
- Prolonged effect since new protein synthesis is required
- Reserpine also depletes 5-HT by inhibiting VMAT
- Tryptophan can be depleted in humans by administering an amino acid mix devoid of
tryptophan - Boost of amino acids triggers protein synthesis in the liver, depleting previous supply of tryptophan
- Neutral amino acids compete for BBB transporters
4
Q
Describe 5 HT releasers
A
- Fenfluramine
- Prescribed for weight loss in obese patients
- Some substituted amphetamines * Para-chloroamphetamine
- Amphetamine analogue used experimentally
- 3,4-methylenedioxymethamphetamine (MDMA)
- Psychoactiverecreationaldrug(Ecstasy)
5
Q
Describe fen-phen
A
- Dopamine and 5-HT are directly opposed in regulating appetite
- Dopamine is released in response to food stimuli (smell), stimulates appetite
- 5-HT generated as a result of eating inhibits dopamine release, decreasing appetite
- Fenfluramine is a 5-HT releaser
- Phentermine supresses appetite through effects on catecholamines (psychostimulant
similar to amphetamine) - Fen-Phen came into use in the 1990’s as an off-label prescription for obesity
- Co-treatment avoided drowsiness and adverse mood effects associated with fenfluramine
6
Q
Describe the effects of Fen-Phen
A
- Fen-Phen was never FDA approved for weight
loss (off-label use) - Several studies published in 1996-7 linked long term Fen-Phen use with severe adverse consequences
- Heart valve abnormalities
- Primary pulmonary hypertension – increased blood
pressure between heart and lungs – often fatal - Both fenfluramine (Pondimin) and dexfenfluramine (Redux) removed from clinical use in late 1997
7
Q
Describe 5-HT transporters
A
- Responsible for inactivation of 5-HT signalling by reuptake
- Similar to DAT, NET
- Many drugs have effects at all three (e.g. cocaine and
amphetamines, antidepressants) - SERT also found in lungs, placenta, and platelets * SERT pumps systemic 5-HT into platelets
- Functions in clotting cascades as a vasoconstrictor
8
Q
How is SERT a popular drug target?
A
- TCA antidepressants (non-selective for SERT, NET)
- Imipramine
- SSRIantidepressants(selectiveforSERT)
- Fluoxetine
- SNRI antidepressants (non-selective for SERT, NET)
- Venlafaxine
- SNDRI antidepressants (SERT ~ NET > DAT)
- Psychoactive drugs (non-selective for SERT, NET, DAT)
- Cocaine, amphetamines, MDMA